Repository logo
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
  • Communities & Collections
  • All of DSpace
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Waqar Anwar"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • Loading...
    Thumbnail Image
    Item
    In-silico identification of potential phytochemicals against selected proteins involved in the pancreatic ductal adenocarcinoma
    (UMT Lahore, 2023-08-11) Aiman Yaseen; Anam Imtiaz; Safa Adrees; Waqar Anwar
    Due to the highly malignant nature of Pancreatic cancer, it is considered as one of the deadliest cancers. Only 5% of patients survive this gastrointestinal malignancy. This cancer has been diagnosed at later stages, mostly 90% spread and metastasized. There is a tiring need to study the underlying mechanism responsible for progression of the disease. There are many proteins that overexpress during this disease. The proteins which were taken into consideration in this study are LIF, NEK, PPP1CA, KLK8. Common mechanisms shared by these proteins are cell proliferation, differentiation, invasiveness, and metastasis. Existing options include surgical resection of infected areas, chemotherapeutic drugs, some combinational therapies as well. There are many drugs which are in phase I and II, some of which are showing better results and some need deeper consideration. The selected proteins were considered as targets and against them potential anti-cancer drugs have been identified. These drugs will inhibit the function of these proteins through which the cancer progresses. Piroxicam was identified as a novel anti-LIF and anti-KLK8 drug. Boeravinone B was identified as a potential inhibitor for NEK7 and PPP1CA.

DSpace software copyright © 2002-2026 LYRASIS

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback